3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
13
Rectal Neoplasms
4
Neoplasm Metastasis
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Advanced Microsatellite Stable Colorectal Cancer
1
Adenomatous Polyposis Coli
1
Interventions
Nivolumab
37
pembrolizumab
30
cabozantinib
27
Specimen Handling
25
Magnetic Resonance Spectroscopy
22
Ipilimumab
20
lenvatinib
16
Axitinib
15
belzutifan
13
CTLA-4 Antigen
10
Sunitinib
9
Biopsy
9
Radiosurgery
8
atezolizumab
7
Immunoglobulin G
5
toripalimab
4
fludarabine
4
avelumab
4
aldesleukin
4
Everolimus
4
Disulfides
4
Cyclophosphamide
4
zimberelimab
3
tivozanib
3
spartalizumab
3
pazopanib
3
palbociclib
3
durvalumab
3
cemiplimab
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
trifluridine tipiracil drug combination
×
90 days
×
Clear all
No trials found.